InvestorsHub Logo
Followers 64
Posts 7221
Boards Moderated 0
Alias Born 05/28/2004

Re: None

Saturday, 06/15/2019 11:47:32 AM

Saturday, June 15, 2019 11:47:32 AM

Post# of 111071
And now, for the rest of the story if the board wants to go back to 2008.

When Ichim and Dickerson inherited the shell to trade it had OS of 132.5 million and they did the small RS to bring the OS from 132.5 to only 5.3 million OS shortly after they acquired the shell. They had no revs, only IP as they had phase 1 clinical in process. Medistem was developed and sold to Intexon, it was never commercialized.

As they developed the company the OS only went up from 5.3 in 2008 to million to 14.4 in 2013. They do not have a history of RS to their shareholders or severe dilution. The dilution we are seeing now is only what is needed to fund the company on its shoestring budget. CELZ is also now cash flowing, but we all know that!!

Comparing the two for this reason is comparing apples to oranges.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News